HIV infection and oligosaccharides: A novel approach to preventing HIV infection and the onset of AIDS

Journal of Infection and Chemotherapy

Volumn 5, Issue 4, 1999, Pages 190-195

  Mizuochi, Tsuguo ^a   Nakata, Munehiro ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Anti HIV agents; Antifungal agents; gp120; High mannose type oligosaccharides; HIV; N linked oligosaccharide

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ASPARAGINE LINKED OLIGOSACCHARIDE; BMY 28864; GLYCOPROTEIN GP 120; IODINE 125; MANNOSE BINDING PROTEIN; OLIGOSACCHARIDE; PRADIMICIN A; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CARBOHYDRATE ANALYSIS; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PROTEIN ANALYSIS; REVIEW; VIRUS INFECTION;

EID: 0033377847     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101560050033     Document Type: Review

References (38)

1. Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984;312:763-7.
2. Hallenberger S, Bosch V, Angliker H, Shaw E, Klenk H-D, Garten W. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature 1992;360:358-61.
3. Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, Gregory TJ. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 1990;265: 10373-82.
4. Allan JS, Coligan JE, Barin F, McLane MF, Sodroski JG, Rosen CA, et al. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science 1985;228:1091-4.
5. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stamvorth D, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985;316:452-7.
6. Mirelman D, editor. Microbial lectins and agglutinins: properties and biological activity. New York , NY: Wiley; 1986.
7. Rosenstein IJ, Stoll MS, Mizuochi T, Childs RA, Hounsell EF, Feizi T. New type adhesive specificity revealed by oligosaccharide probes in Escherichia coli from patients with urinary tract infection. Lancet 1988;II:1327-30.
8. Berger EA, Fuerst TR, Moss B. A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus. Proc Natl Acad Sei USA 1988;85:2357-61.
9. Traunecker A, Luke W, Karjalainen K. Soluble CD4 molecules neutralize human immunodeficiency virus type 1. Nature 1988;331:84-6.
10. Capon DJ, Chamow SM, Mordenti J, Marsters SA, Gregory T, Mitsuya H, et al. Designing CD4 immunoadhesins for AIDS therapy. Nature 1989;337:525-31.
11. Arthos J, Deen KC, Chaikin MA, Fornwald JA, Sathe G, Sattentau QJ, et al. Identification of the residues in human CD4 critical for the binding of HIV. Cell 1989;57:469-81.
12. Fennie C, Lasky LA. Model for intracellular folding of the human immunodeficiency virus type 1 gp120. J Virol 1989;63:639-46.
13. Matthews TJ, Weinhold KJ, Lyerly HK, Langlois AJ, Wigzell H, Bolognesi DP. Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proc Natl Acad Sci USA 1987;84:5424-8.
14. Gruters RA, Neefjes JJ, Tersmette M, de Goede REY, Tulp A, Huisman HG, et al. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature 1987;330:74-7.
15. Montefiori DC, Robinson WE Jr, Mitchell WM. Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. Proc Natl Acad Sei USA 1988;85:9248-52.
16. Pal R, Hoke GM, Sarngadharan MG. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1. Proc Natl Acad Sei USA 1989;86: 3384-8.
17. Mizuochi T, Spellman MW, Larkin M, Solomon J, Basa LJ, Feizi T. Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells. Biochem J 1988;254:599-603.
18. Feizi T, Larkin M. AIDS and glycosylation. Glycobiology 1990;1:17-23.
19. Mizuochi T, Spellman MW, Larkin M, Solomon J, Basa LJ, Feizi T. Structural characterization by chromatographic profiling of the oligosaccharides of human immunodeficiency virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese hamster ovary cells. Biomed Chromatogr 1988;2:260-70.
20. Mizuochi T, Matthews TJ, Kato M, Hamako J, Titani K, Solomon J, et al. Diversity of oligosaccharide structures on the envelope glycoprotein gp120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9: presence of complex-type oligosac-charides with bisecting N-acetylglucosamine. J Biol Chem 1990; 265:8519-24.
21. Mizuochi T. Structure and function of oligosaccharide chains of the envelope glycoprotein gp120 of human immunodeficiency virus type 1 (in Japanese). Jpn J Clin Med 1992;50:1419-29.
22. Lifson J, Coutre S, Huang E, Engleman E. Role of envelope glyco-protein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion. J Exp Med 1986;164:2101-6.
23. Kawasaki N, Kawasaki T, Yamashina I. Isolation and characterization of a mannan-binding protein from human serum. J Biochem (Tokyo) 1983;94:937-47.
24. Childs RA, Drickamer K, Kawasaki T, Thiel S, Mizuochi T, Feizi T. Neoglycolipids as probes of oligosaccharide recognition by recombinant and natural mannose-binding proteins of the rat and man. Biochem J 1989;262:131-8.
25. Nakata M, Shikata K, Mizuochi T. Abnormality in IgG oligosac-charides and activation of complement system by mannose-binding protein (in Japanese). Clin Immunol 1997;29:162-8.
26. Holmskov U, Malhotra R, Sim RB, Jensenius JC. Collectins: collagenous C-type lectins of the innate immune defense system. Immunol Today 1994;15:67-74.
27. Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996;17:532-40.
28. Larkin M, Childs RA, Matthews TJ, Thiel S, Mizuochi T, Lawson AM, et al. Oligosaccharide-mediated interactions of the envelope glycoprotein gp120 of HIV-1 that are independent of CD4 recognition. AIDS 1989;3:793-8.
29. Mizuochi T, Loveless RW, Lawson AM, Chai W, Lachmann PJ, Childs RA, et al. A library of oligosaccharide probes (neoglycolipids) from N-glycosylated proteins reveals that conglutinin binds to certain complex-type as well as high mannose-type oligosaccharide chains. J Biol Chem 1989;264:13834-9.
30. Ezekowitz RAB, Kuhlman M, Groopman JE, Byrn RA. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med 1989;169:185-96.
31. Hideshima T, Okada N, Okada H. Expression of HRF20, a regulatory molecule of complement activation, on peripheral blood mononuclear cells. Immunology 1990;69:396-401.
32. Boyer V, Desgranges C, Trabaud MA, Fischer E, Kazatchkine MD. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. J Exp Med 1991;173:1151-8.
33. Oki T, Konishi M, Tomatsu K, Tomita K, Saitoh K, Tsunakawa M, et al. Pradimicin, a novel class of potent antifungal antibiotics. J Antibiot (Tokyo) 1988;41:1701-4.
34. Oki T, Kakushima M, Nishio M, Kamei H, Hirano M, Sawada Y, et al. Water-soluble pradimicin derivatives, synthesis and antifungal evaluation of N,N-dimethyl pradimicins. J Antibiot (Tokyo) 1990;43:1230-5.
35. Tanabe-Tochikura A, Tochikura T, Yoshida O, Oki T, Yamamoto N. Pradimicin A inhibition of human immunodeficiency virus: attenuation by mannan. Virology 1990;176:467-73.
36. Mizuochi T, Nakata M, Fujita K, Oki T, Murakami T, Nakashima H, et al. Inhibition of HIV infection by targeting the oligosaccha-ride chains of HIV envelope glycoprotein. AIDS Res Newsletter 1993;7:162.
37. Sawada Y, Murakami T, Ueki T, Fukagawa Y, Oki T, Nozawa Y. Mannan-mediated anticandidal activity of BMY-28864, a new water-soluble pradimicin derivative. J Antibiot (Tokyo) 1991; 44:119-21.
38. Kojima N, Hakomori S. Specific interaction between gangliotriosylceramide (Gg3) and sialosyllactosylceramide (GM3) as a basis for specific cellular recognition between lymphoma and melanoma cells. J Biol Chem 1989;264:20159-62.